Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAST ACT: Dexamethasone in TBM
NCT03100786Phase 3Completed
- Sponsor
- Oxford University Clinical Research Unit
- Start
- Feb 2018
- Primary completion
- Mar 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dexamethasone in tuberculous meningitis (TBM), sponsored by Oxford University Clinical Research Unit. Started Feb 2018; status: completed.
02
Drugs
dexamethasone
03
Conditions
tuberculous meningitis (TBM)
Beyond the preview
Go deeper on NCT03100786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03100786.